Fred Alger Management, LLC Athenex, Inc. Transaction History

Fred Alger Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$9.6 - $17.75 $96,000 - $177,500	-10,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$12.16 - $21.0 $547,200 - $945,000	-45,000 Reduced 81.82%	10,000 $122,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $519,200 - $1.09 Million	55,000 New	55,000 $1.09 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.